These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 17046051

  • 21. Effect of asymmetric dimethylarginine on atherogenesis and erythrocyte deformability in apolipoprotein E deficient mice.
    Xiao HB, Yang ZC, Jia SJ, Li NS, Jiang DJ, Zhang XH, Guo R, Zhou Z, Deng HW, Li YJ.
    Life Sci; 2007 Jun 13; 81(1):1-7. PubMed ID: 17532008
    [Abstract] [Full Text] [Related]

  • 22. Alpha-galactosidase A deficiency accelerates atherosclerosis in mice with apolipoprotein E deficiency.
    Bodary PF, Shen Y, Vargas FB, Bi X, Ostenso KA, Gu S, Shayman JA, Eitzman DT.
    Circulation; 2005 Feb 08; 111(5):629-32. PubMed ID: 15668341
    [Abstract] [Full Text] [Related]

  • 23. Atherosclerosis development in apolipoprotein E-null mice deficient for CD69.
    Gómez M, Sanz-González SM, Abu Nabah YN, Lamana A, Sánchez-Madrid F, Andrés V.
    Cardiovasc Res; 2009 Jan 01; 81(1):197-205. PubMed ID: 18703531
    [Abstract] [Full Text] [Related]

  • 24. The role of complement in the adherence of microbubbles to dysfunctional arterial endothelium and atherosclerotic plaque.
    Anderson DR, Tsutsui JM, Xie F, Radio SJ, Porter TR.
    Cardiovasc Res; 2007 Feb 01; 73(3):597-606. PubMed ID: 17196951
    [Abstract] [Full Text] [Related]

  • 25. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
    Oumouna-Benachour K, Hans CP, Suzuki Y, Naura A, Datta R, Belmadani S, Fallon K, Woods C, Boulares AH.
    Circulation; 2007 May 08; 115(18):2442-50. PubMed ID: 17438151
    [Abstract] [Full Text] [Related]

  • 26. Decreased levels of lipid peroxidation-induced DNA damage in the onset of atherogenesis in apolipoprotein E deficient mice.
    Godschalk RW, Albrecht C, Curfs DM, Schins RP, Bartsch H, van Schooten FJ, Nair J.
    Mutat Res; 2007 Aug 01; 621(1-2):87-94. PubMed ID: 17418875
    [Abstract] [Full Text] [Related]

  • 27. Endothelial nitric oxide deficiency reduces MMP-13-mediated cleavage of ICAM-1 in vascular endothelium: a role in atherosclerosis.
    Tarín C, Gomez M, Calvo E, López JA, Zaragoza C.
    Arterioscler Thromb Vasc Biol; 2009 Jan 01; 29(1):27-32. PubMed ID: 18988893
    [Abstract] [Full Text] [Related]

  • 28. Oral administration of tetrahydrobiopterin slows the progression of atherosclerosis in apolipoprotein E-knockout mice.
    Hattori Y, Hattori S, Wang X, Satoh H, Nakanishi N, Kasai K.
    Arterioscler Thromb Vasc Biol; 2007 Apr 01; 27(4):865-70. PubMed ID: 17272747
    [Abstract] [Full Text] [Related]

  • 29. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
    Bousette N, D'Orleans-Juste P, Kiss RS, You Z, Genest J, Al-Ramli W, Qureshi ST, Gramolini A, Behm D, Ohlstein EH, Harrison SM, Douglas SA, Giaid A.
    Circ Res; 2009 Sep 25; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
    [Abstract] [Full Text] [Related]

  • 30. Uremia-specific effects in the arterial media during development of uremic atherosclerosis in apolipoprotein E-deficient mice.
    Bro S, Borup R, Andersen CB, Moeller F, Olgaard K, Nielsen LB.
    Arterioscler Thromb Vasc Biol; 2006 Mar 25; 26(3):570-5. PubMed ID: 16373611
    [Abstract] [Full Text] [Related]

  • 31. Proteomic profiles of serum inflammatory markers accurately predict atherosclerosis in mice.
    Tabibiazar R, Wagner RA, Deng A, Tsao PS, Quertermous T.
    Physiol Genomics; 2006 Apr 13; 25(2):194-202. PubMed ID: 16418319
    [Abstract] [Full Text] [Related]

  • 32. The long-term effect of angiotensin II type 1a receptor deficiency on hypercholesterolemia-induced atherosclerosis.
    Eto H, Miyata M, Shirasawa T, Akasaki Y, Hamada N, Nagaki A, Orihara K, Biro S, Tei C.
    Hypertens Res; 2008 Aug 13; 31(8):1631-42. PubMed ID: 18971539
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of aortic remodeling in apolipoprotein E-deficient mice and renovascular hypertensive mice.
    Nogueira BV, Peotta VA, Meyrelles SS, Vasquez EC.
    Arch Med Res; 2007 Nov 13; 38(8):816-21. PubMed ID: 17923260
    [Abstract] [Full Text] [Related]

  • 34. Blockade of scavenger receptor class B type I raises high density lipoprotein cholesterol levels but exacerbates atherosclerotic lesion formation in apolipoprotein E deficient mice.
    Kitayama K, Nishizawa T, Abe K, Wakabayashi K, Oda T, Inaba T, Amemiya Y.
    J Pharm Pharmacol; 2006 Dec 13; 58(12):1629-38. PubMed ID: 17331327
    [Abstract] [Full Text] [Related]

  • 35. Connexin37 protects against atherosclerosis by regulating monocyte adhesion.
    Wong CW, Christen T, Roth I, Chadjichristos CE, Derouette JP, Foglia BF, Chanson M, Goodenough DA, Kwak BR.
    Nat Med; 2006 Aug 13; 12(8):950-4. PubMed ID: 16862155
    [Abstract] [Full Text] [Related]

  • 36. Direct evidence for a crucial role of the arterial wall in control of atherosclerosis susceptibility.
    Pei H, Wang Y, Miyoshi T, Zhang Z, Matsumoto AH, Helm GA, Tellides G, Shi W.
    Circulation; 2006 Nov 28; 114(22):2382-9. PubMed ID: 17101850
    [Abstract] [Full Text] [Related]

  • 37. Mapping, genetic isolation, and characterization of genetic loci that determine resistance to atherosclerosis in C3H mice.
    Wang SS, Shi W, Wang X, Velky L, Greenlee S, Wang MT, Drake TA, Lusis AJ.
    Arterioscler Thromb Vasc Biol; 2007 Dec 28; 27(12):2671-6. PubMed ID: 17916774
    [Abstract] [Full Text] [Related]

  • 38. Melagatran reduces advanced atherosclerotic lesion size and may promote plaque stability in apolipoprotein E-deficient mice.
    Bea F, Kreuzer J, Preusch M, Schaab S, Isermann B, Rosenfeld ME, Katus H, Blessing E.
    Arterioscler Thromb Vasc Biol; 2006 Dec 28; 26(12):2787-92. PubMed ID: 16990551
    [Abstract] [Full Text] [Related]

  • 39. Long-term administration of 3-deazaadenosine does not alter progression of advanced atherosclerotic lesions in apolipoprotein E-deficient mice.
    Preusch MR, Bea F, Yang SH, Kreuzer J, Isermann B, Pedal I, Rosenfeld ME, Katus HA, Blessing E.
    J Cardiovasc Pharmacol; 2007 Aug 28; 50(2):206-12. PubMed ID: 17703138
    [Abstract] [Full Text] [Related]

  • 40. Deficiency of the long pentraxin PTX3 promotes vascular inflammation and atherosclerosis.
    Norata GD, Marchesi P, Pulakazhi Venu VK, Pasqualini F, Anselmo A, Moalli F, Pizzitola I, Garlanda C, Mantovani A, Catapano AL.
    Circulation; 2009 Aug 25; 120(8):699-708. PubMed ID: 19667236
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.